Related Experiment Video
Updated: Sep 12, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Improving Treatment Adherence in Youths With Multidrug-Resistant Tuberculosis With Psychosocial Intervention
Gauri Dhumal1,2, Neetal Nevrekar1,2, Nikhil Gupte1
1Johns Hopkins Center for Infectious Diseases in India, Pune, Maharashtra, India.
Introduction:
Multidrug-resistant tuberculosis (MDR-TB) deeply impacts the well-being of adolescents and young adults (AYA), resulting in poor treatment adherence. Identifying psychosocial challenges and preferred interventions is essential to enhance treatment adherence and outcomes in this unique group.
Methods:
This was a mixed-method study where participants aged between 15 and 24 years, diagnosed with MDR-TB, were recruited for in-depth interviews and a semi-structured questionnaire.
Results:
The individual-level psychosocial challenges included mental stress, suicidal ideation, reluctance to continue medication, perceived and experienced stigma, and socio-economic burdens. Health system-related challenges encompassed delayed diagnosis, drug stockouts, and negative experiences with Health Care Providers (HCPs). Among 75 participants, the median age was 20.5 years, with 57% (n = 41) females, 85% (n = 62) single, and a median treatment duration of 8 months at the interview. Seventy-two percent (n = 54) of the participants reported psychological issues such as irritation, loneliness, anxiety, sleep disorder, suicidal ideation, and stigma. Individual-level interventions were preferred by 61% (n = 46) of participants, including social media, deep breathing, and exercise training.
Conclusions:
To enhance results in MDR-TB, it is crucial to develop and assess personalized psychosocial interventions with tailored adjustments to tackle the psychosocial obstacles encountered by adolescents and young adults with MDR-TB.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Drug Therapy
Antianxiety Medications
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...

